CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Constellation Pharmaceuticals Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Constellation Pharmaceuticals Inc
215 1st St Ste 200
Phone: (617) 714-0555p:617 714-0555 CAMBRIDGE, MA  02142-1293  United States Ticker: CNSTCNST

Business Summary
Constellation Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is primarily if focused on discovering and developing therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression and drug resistance. The Company has two clinical-stage oncology development programs: the first program is evaluating a compound, CPI-1205, and the other program is evaluating a compound, CPI-0610.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201912/31/2018YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board Mark A.Goldsmith 57 7/1/2009 7/1/2009
President, Chief Executive Officer, Director JigarRaythatha 42 3/1/2017 3/1/2017
Chief Financial Officer, Senior Vice President, Treasurer EmmaReeve 58 12/1/2017 10/1/2017
9 additional Officers and Directors records available in full report.

Business Names
Business Name
CNST
Constellation Securities Corporation

General Information
Number of Employees: 82 (As of 2/28/2019)
Outstanding Shares: 33,535,749 (As of 10/31/2019)
Shareholders: 147
Stock Exchange: NASD
Federal Tax Id: 000973343
Fax Number: (617) 577-0472


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, December 05, 2019